- Home
- CBNK vs FATE Comparison
CBNK vs FATE Comparison
Compare CBNK & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- FATE
- Stock Information
- Founded
- CBNK 1974
- FATE 2007
- Country
- CBNK United States
- FATE United States
- Employees
- CBNK N/A
- FATE N/A
- Industry
- CBNK Major Banks
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CBNK Finance
- FATE Health Care
- Exchange
- CBNK Nasdaq
- FATE Nasdaq
- Market Cap
- CBNK 462.4M
- FATE 406.5M
- IPO Year
- CBNK 2018
- FATE 2013
- Fundamental
- Price
- CBNK $29.07
- FATE $1.27
- Analyst Decision
- CBNK Hold
- FATE Hold
- Analyst Count
- CBNK 1
- FATE 10
- Target Price
- CBNK $32.00
- FATE $6.75
- AVG Volume (30 Days)
- CBNK 59.7K
- FATE 3.2M
- Earning Date
- CBNK 01-28-2025
- FATE 02-24-2025
- Dividend Yield
- CBNK 1.38%
- FATE N/A
- EPS Growth
- CBNK N/A
- FATE N/A
- EPS
- CBNK 2.33
- FATE N/A
- Revenue
- CBNK $157,884,000.00
- FATE $13,447,000.00
- Revenue This Year
- CBNK N/A
- FATE N/A
- Revenue Next Year
- CBNK $28.67
- FATE N/A
- P/E Ratio
- CBNK $12.45
- FATE N/A
- Revenue Growth
- CBNK 0.41
- FATE N/A
- 52 Week Low
- CBNK $19.02
- FATE $1.04
- 52 Week High
- CBNK $31.22
- FATE $8.83
- Technical
- Relative Strength Index (RSI)
- CBNK 57.32
- FATE 31.94
- Support Level
- CBNK $26.49
- FATE $1.22
- Resistance Level
- CBNK $28.28
- FATE $1.36
- Average True Range (ATR)
- CBNK 0.62
- FATE 0.15
- MACD
- CBNK 0.05
- FATE -0.02
- Stochastic Oscillator
- CBNK 100.00
- FATE 24.21
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, Corporate Office, and OpenSky. Its Commercial Banking division offers banking-related services to clients, Capital Bank Home Loans division offers conventional and government-guaranteed residential mortgage loans on a nationwide basis for sale into the secondary market, while its OpenSky division provides secured credit cards on a nationwide basis to under-banked populations and those looking to rebuild their credit scores.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.